On the relative role of different age groups in influenza epidemics

Epidemics

Volumn 13, Issue , 2015, Pages 10-16

  Worby, Colin J ^a   Chaves, Sandra S ^b   Wallinga, Jacco ^c   Lipsitch, Marc ^a   Finelli, Lyn ^b   Goldstein, Edward ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Age groups; Epidemics; Influenza; Relative risk; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; EPIDEMIC; HUMAN; INFANT; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MIDDLE AGED; NEWBORN; PRIORITY JOURNAL; RISK FACTOR;

EID: 84929308354     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2015.04.003     Document Type: Article

References (27)

1. Basta N.E., Chao D.L., Halloran M.E., Longini I.M. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am. J. Epidemiol. 2009, 170:679-686.
2. Cauchemez S., Valleron A.J., Böelle P.Y., Flahaut A., Ferguson N.M. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature 2008, 452:750-754.
3. Cauchemez S., Donnelly C.A., Reed C., Ghani A.C., Fraser C., et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. New Engl. J. Med. 2009, 361:2619-2627.
4. CDC 2009-2010 Influenza Season Week 2 ending January 16, 2010 2010, CDC, 〈http://www.cdc.gov/flu/weekly/weeklyarchives2009-2010/weekly02.htm〉 (accessed September 4th, 2014).
5. CDC Flu Vaccination Coverage 2013, CDC, 〈http://www.cdc.gov/flu/fluvaxview/coverage-1213estimates.htm〉 (accessed September 4th, 2014).
6. Flasche S., Hens N., Böelle P.Y., Mossong J., van Ballegooijen W.M., et al. Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries. Epidemics 2011, 3:125-133.
7. Goldstein E., Apolloni A., Lewis B., Miller J.C., Macauley M., et al. Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J. R. Soc. Interface 2010, 7:755-764.
8. Goldstein E., Cobey S., Takahashi S., Miller J.C., Lipsitch M. Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med. 2011, 8:e1001051.
9. Goldstein E., Wallinga J., Lipsitch M. Vaccine allocation in a declining epidemic. J. R. Soc. Interface 2012, 9:2798-2803.
10. Huang K.E., Lipsitch M., Shaman J., Goldstein E. The US 2009 A(H1N1) influenza epidemic: quantifying the impact of school openings on the reproductive number. Epidemiology 2014, 25:203-206.
11. Jackson C., Vynnycky E., Hawker J., Olowokure B., Mangtani P. School closures and influenza: systematic review of epidemiological studies. BMJ Open 2013, 3:e002149.
12. Jackson L., Jackson M.L., Phillips C.H. Interim adjusted estimates of seasonal influenza vaccine effectiveness-United States, February 2013. Morb. Mortal. Wkly. Rep. 2013, 62:119-123.
13. Keeling M.J., Rohani P. Modeling Infectious Diseases in Humans and Animals 2008, Princeton University Press, Princeton, NJ.
14. Loeb M., Russell M.L., Moss L., Fonseca K., Fox J., et al. Effect of influenza vaccination of children on infection rates in hutterite communities. JAMA 2010, 303:943-950.
15. Longini I.M., Halloran M.E., Nizam A., Yang Y. Containing pandemic influenza with antiviral agents. Am. J. Epidemiol. 2004, 159:623-633.
16. MacIntosh V.H., Tastad K.J., Eick-Cost A.A. Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate. Vaccine 2013, 31:1651-1655.
17. Monto A., Kioumehr F. The tecumseh study of respiratory illness IX. Occurence of influenza in the community, 1966-1971. Am. J. Epidemiol. 1975, 102:1975.
18. Monto A., Koopman J., Longini I.M. Tecumseh study of illness, XIII. Influenza infection and disease, 1976-1981. Am. J. Epidemiol. 1985, 102:553-563.
19. Mossong J., Hens N., Jit M., Beutels P., Auranen K., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008, 5:e74.
20. Ndeffo Mbah M.L., Medlock J., Meyers L.A., Galvani A.P., Townsend J.P. Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine 2013, 31:3079-3089.
21. Olson D.R., Heffernan R.T., Paladini M., Konty K., Weiss D., et al. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007, 4:e247.
22. Reed C., Katz J., Hancock K., Balish A., Fry A., et al. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic. PLoS ONE 2012, 7:e48187.
23. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., et al. The Japanese experience with vaccinating schoolchildren against influenza. New Engl. J. Med. 2001, 344:889-896.
24. Schanzer D., Vachon J., Pelletier L. Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics?. Am. J. Epidemiol. 2011, 174:109-117.
25. Singleton J.A., Santibanez T.A., Lu P.J. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage-United States, October-December 2009. Morb. Mortal. Wkly. Rep. 2010, 59:44-48.
26. Wallinga J., Teunis P., Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am. J. Epidemiol. 2006, 164:936-944.
27. Wallinga J., van Boven M., Lipsitch M. Optimizing infectious disease interventions during an emerging epidemic. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:923-928.